What we do.
Emerging markets offer exciting potential. However, these markets are uncertain, less understood, and constantly changing. How can global pharma hope to ensure success in these unchartered territories?
Our emerging markets team can help. Over one third of the projects we manage cover one or more of the key countries ear-marked for growth. We carry out large-scale qualitative and quantitative studies across a range of therapy areas, throughout the product lifecycle, in BRIC, and beyond.